319 related articles for article (PubMed ID: 23517658)
1. Existing arrangements for monitoring community pharmacies in England: can they have a role in the revalidation of pharmacists?
Jacobs S; Schafheutle EI; Jee SD; Elvey R; Hassell K; Noyce PR
Res Social Adm Pharm; 2013; 9(2):166-77. PubMed ID: 23517658
[TBL] [Abstract][Full Text] [Related]
2. An exploration of the utility of appraisals for the revalidation of pharmacy professionals in community pharmacy in Great Britain.
Jee SD; Jacobs S; Schafheutle EI; Elvey R; Hassell K; Noyce PR
Res Social Adm Pharm; 2013; 9(2):155-65. PubMed ID: 23517657
[TBL] [Abstract][Full Text] [Related]
3. Pharmacists' and pharmacy technicians' views on a process of revalidation of pharmacy professionals in Great Britain.
Potter H; Hassell K; Noyce PR
Res Social Adm Pharm; 2013; 9(2):142-54. PubMed ID: 23517656
[TBL] [Abstract][Full Text] [Related]
4. Ensuring continuing fitness to practice in the pharmacy workforce: Understanding the challenges of revalidation.
Schafheutle EI; Hassell K; Noyce PR
Res Social Adm Pharm; 2013; 9(2):199-214. PubMed ID: 23517660
[TBL] [Abstract][Full Text] [Related]
5. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
Wells KM; Thornley T; Boyd MJ; Boardman HF
Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
[TBL] [Abstract][Full Text] [Related]
6. Revalidation arrangements for pharmacy professionals in industry and academia in Great Britain: a qualitative study.
Elvey R; Schafheutle EI; Jacobs S; Jee SD; Hassell K; Noyce PR
Res Social Adm Pharm; 2013; 9(2):178-87. PubMed ID: 23517659
[TBL] [Abstract][Full Text] [Related]
7. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
[TBL] [Abstract][Full Text] [Related]
8. Career breaks and changes of sector: challenges for the revalidation of pharmacists.
Phipps DL; Noyce PR; Walshe K; Ashcroft DM; Parker D
Res Social Adm Pharm; 2013; 9(2):188-98. PubMed ID: 23040676
[TBL] [Abstract][Full Text] [Related]
9. Governance and the pharmaceutical workforce in England.
Noyce P
Res Social Adm Pharm; 2006 Sep; 2(3):408-19. PubMed ID: 17138523
[TBL] [Abstract][Full Text] [Related]
10. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
[TBL] [Abstract][Full Text] [Related]
11. Fitness for purpose of pharmacy technician education and training: The case of Great Britain.
Schafheutle EI; Jee SD; Willis SC
Res Social Adm Pharm; 2017; 13(1):88-97. PubMed ID: 26827123
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
13. The role of information technology in the development of community pharmacy services: visions and strategic views of international experts.
Westerling AM; Haikala V; Airaksinen M
Res Social Adm Pharm; 2011 Dec; 7(4):430-7. PubMed ID: 21272534
[TBL] [Abstract][Full Text] [Related]
14. Exploring opportunities for providing pharmacists with feedback on their practice and performance around the electronic Minor Ailments Service in Scotland.
Paudyal V; Hansford D; Cunningham S; Stewart D
Int J Pharm Pract; 2014 Oct; 22(5):319-26. PubMed ID: 24423237
[TBL] [Abstract][Full Text] [Related]
15. A qualitative study exploring community pharmacists' awareness of, and contribution to, self-care support in the management of long-term conditions in the United Kingdom.
Ogunbayo OJ; Schafheutle EI; Cutts C; Noyce PR
Res Social Adm Pharm; 2015; 11(6):859-79. PubMed ID: 25677228
[TBL] [Abstract][Full Text] [Related]
16. Restructuring supervision and reconfiguration of skill mix in community pharmacy: Classification of perceived safety and risk.
Bradley F; Willis SC; Noyce PR; Schafheutle EI
Res Social Adm Pharm; 2016; 12(5):733-46. PubMed ID: 26642961
[TBL] [Abstract][Full Text] [Related]
17. Performance of community pharmacists in providing clinical medication reviews.
Laaksonen R; Duggan C; Bates I
Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
[TBL] [Abstract][Full Text] [Related]
18. The impact of increasing workloads and role expansion on female community pharmacists in the United Kingdom.
Gidman WK; Hassell K; Day J; Payne K
Res Social Adm Pharm; 2007 Sep; 3(3):285-302. PubMed ID: 17945159
[TBL] [Abstract][Full Text] [Related]
19. From community pharmacy to healthy living pharmacy: positive early experiences from Portsmouth, England.
Brown D; Portlock J; Rutter P; Nazar Z
Res Social Adm Pharm; 2014; 10(1):72-87. PubMed ID: 23731701
[TBL] [Abstract][Full Text] [Related]
20. Professional stakeholders' expectations for the future of community pharmacy practice in England: a qualitative study.
Paloumpi E; Ozieranski P; Watson MC; Jones MD
BMJ Open; 2023 Oct; 13(10):e075069. PubMed ID: 37844992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
